Elutia Inc. (ELUT) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Elutia reported revenue of $12.3M, down 49.6% from $24.4M the year before. Net income was $53.4M (a 434.2% net margin), or $0.87 per diluted share. Gross margin was 53.7% and operating margin was -218.9%. Operating activities generated -$44.8M of cash, leaving -$46.7M of free cash flow. At fiscal year end, Elutia held $62.4M in total assets against $34.7M in total liabilities, including $36.4M of cash and equivalents.
Open the full interactive Elutia financials → Quarterly statements, key ratios, valuation history and price charts.
Elutia Key Stats
| Share Price | $0.77 |
|---|---|
| Market Cap | $34.2M |
| P/E Ratio | 0.9 |
| Revenue YoY Growth | -49.6% |
| 52-Week Range | $0.50 – $1.22 |
| Shares Outstanding | 44.2 million (basic, 2026 Q2) |
Elutia Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $42.7M | $47.4M | $49.2M | $24.7M | $24.4M | $12.3M |
| Cost of Goods Sold | $22.1M | $28.4M | $30.0M | $13.7M | $13.7M | $5.7M |
| Gross Profit | $20.6M | $19.0M | $19.2M | $11.1M | $10.7M | $6.6M |
| Operating Income | -$13.6M | -$23.0M | -$31.7M | -$30.5M | -$35.7M | -$26.9M |
| Pre-Tax Income | -$21.8M | -$24.8M | -$32.9M | -$41.2M | -$54.1M | -$15.9M |
| Income Tax | $26,000 | $55,000 | $34,000 | $28,000 | $7,000 | $13,000 |
| Net Income | -$21.8M | -$24.8M | -$32.9M | -$37.7M | -$53.9M | $53.4M |
| Diluted EPS | -$8.88 | -$2.38 | -$2.38 | -$2.07 | -$1.86 | $0.87 |
Elutia Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.3M | — | $3.1M | $2.4M |
| Net Income | -$3.9M | $70.8M | -$7.5M | -$7.6M |
| Diluted EPS | -$0.19 | $1.54 | -$0.17 | -$0.17 |
Elutia Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $39.1M | $30.4M | $17.0M | $19.3M | $13.2M | $36.4M |
| Current Assets | $59.7M | $47.4M | $50.7M | $31.3M | $26.2M | $55.8M |
| Total Assets | $82.8M | $67.2M | $68.8M | $43.4M | $36.1M | $62.4M |
| Current Liabilities | $26.8M | $26.0M | $42.6M | $43.0M | $37.8M | $25.1M |
| Total Long-Term Debt | $24.1M | $18.5M | $24.3M | $20.4M | $22.6M | — |
| Total Liabilities | $62.0M | $53.6M | $73.9M | $82.0M | $82.4M | $34.7M |
| Shareholders' Equity | $20.8M | $13.5M | -$5.0M | -$38.6M | -$46.3M | $27.7M |
Elutia Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$13.6M | -$15.4M | -$21.4M | -$21.8M | -$22.7M | -$44.8M |
| Cash From Investing | -$640,000 | -$369,000 | -$540,000 | $14.2M | -$474,000 | $78.6M |
| Cash From Financing | $51.2M | $6.7M | $8.5M | $9.8M | $17.1M | -$10.6M |
| Free Cash Flow | -$14.3M | -$15.8M | -$21.9M | -$22.1M | -$23.4M | -$46.7M |
Figures from Elutia's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Elutia financials page for every line item.
Elutia Company Profile
| Ticker | ELUT |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Silver Spring, Maryland |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001708527 |
Frequently Asked Questions
What was Elutia's revenue in fiscal 2025?
Elutia (ELUT) reported revenue of $12.3M for fiscal 2025.
What is Elutia's annual revenue history?
Elutia's annual revenue by fiscal year: 2020: $42.7M; 2021: $47.4M; 2022: $49.2M; 2023: $24.7M; 2024: $24.4M; 2025: $12.3M.
What was Elutia's net income in fiscal 2025?
Elutia reported net income of $53.4M for fiscal 2025.
What was Elutia's earnings per share (EPS) in fiscal 2025?
Elutia's diluted EPS was $0.87 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Elutia generate in fiscal 2025?
Elutia generated -$46.7M of free cash flow in fiscal 2025.
What was Elutia's revenue last quarter?
In its most recent reported quarter (2026 Q2), Elutia reported revenue of $2.4M.
How many shares of Elutia are outstanding?
Elutia reported a weighted average of 44.2 million basic shares outstanding in 2026 Q2.
What is Elutia's market cap?
Based on its latest closing price, Elutia (ELUT) has a market capitalization of about $34.2M.
When does Elutia's fiscal year end?
Elutia's fiscal year end, as registered with the SEC, is December 31.
Where is Elutia headquartered?
Elutia lists its business address in Silver Spring, Maryland in its SEC filings.
Elutia Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →